# FDA Inspection 1230113 - EyePoint Pharmaceuticals, Inc. - February 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/96011f71-7dc7-4d1e-af2a-8fb571d5f403
Source feed: FDA_Inspections

> FDA Inspection 1230113 for EyePoint Pharmaceuticals, Inc. on February 15, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230113
- Company Name: EyePoint Pharmaceuticals, Inc.
- Inspection Date: 2024-02-15
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1150669 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bc7824a1-722e-4a03-8af8-91a2affaaa96)
- [FDA Inspection 1102130 - 2019-08-28](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bd40ecfd-6d7a-4c39-8319-1d042041f48b)

Company: https://www.keypedia.com/companies/eyepoint-pharmaceuticals-inc/ca6562a2-b315-4e33-b9b2-394c1c8ad945

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144